However, this work concentrated on only one serotonin receptor, the 5-HT 4 receptor. The researchers began by scanning the brains of 90 depressed patients, to measure the quantity of 5-HT 4 ...

Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.